Because STAT3 is constitutively activated in CLL and activates several STAT3 target genes [15] and miR-155 is overexpressed in CLL [19], we sought to determine whether miR-155 has any STAT3 binding sites. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.